295 related articles for article (PubMed ID: 16998774)
1. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?
Hyde TB; Kruszon-Moran D; McQuillan GM; Cossen C; Forghani B; Reef SE
Clin Infect Dis; 2006 Nov; 43 Suppl 3():S146-50. PubMed ID: 16998774
[TBL] [Abstract][Full Text] [Related]
2. Rubella seropositivity in the United States, 1988-1994.
Dykewicz CA; Kruszon-Moran D; McQuillan GM; Williams WW; Van Loon FP; Cossen C; Forghani B; Hadler SC
Clin Infect Dis; 2001 Oct; 33(8):1279-86. PubMed ID: 11565065
[TBL] [Abstract][Full Text] [Related]
3. Has the United States population been adequately vaccinated to achieve rubella elimination?
Bloom S; Smith P; Stanwyck C; Stokley S
Clin Infect Dis; 2006 Nov; 43 Suppl 3():S141-5. PubMed ID: 16998773
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of rubella among Jordanian women of childbearing age.
Jarour N; Hayajneh WA; Balbeesi A; Otoom H; Al-Shurman A; Kharabsheh S
Vaccine; 2007 May; 25(18):3615-8. PubMed ID: 17280747
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.
Pourabbas B; Ziyaeyan M; Alborzi A; Mardaneh J
Int J Infect Dis; 2008 Jan; 12(1):43-6. PubMed ID: 17950020
[TBL] [Abstract][Full Text] [Related]
6. Rubella seroprevalence among women of childbearing age residing in a rural region: is there a need for rubella vaccination in Turkey?
Aksakal FN; Maral I; Cirak MY; Aygun R
Jpn J Infect Dis; 2007 Jul; 60(4):157-60. PubMed ID: 17642522
[TBL] [Abstract][Full Text] [Related]
7. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine.
Riddell M; Senn N; Clements CJ; Hobday L; Cowie B; Kurubi J; Kevin A; Siba P; Reeder JC; Morgan C
Vaccine; 2012 Dec; 30(52):7506-12. PubMed ID: 23103194
[TBL] [Abstract][Full Text] [Related]
8. Seroepidemiological survey of rubella immunity among three populations in Shiraz, Islamic Republic of Iran.
Doroudchi M; Dehaghani AS; Emad K; Ghaderi AA
East Mediterr Health J; 2001; 7(1-2):128-38. PubMed ID: 12596962
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of rubella infection after national immunization program in Taiwan: vaccination status and immigration impact.
Wang IJ; Huang LM; Chen HH; Hwang KC; Chen CJ
J Med Virol; 2007 Jan; 79(1):97-103. PubMed ID: 17133552
[TBL] [Abstract][Full Text] [Related]
10. [Immune response of rubella vaccine in the populations with different age groups].
Xiong XW; Diao LD; Yan XL
Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
[TBL] [Abstract][Full Text] [Related]
11. [Determining factors of rubella in the 10 to 14 year-old population in Mexico].
Tapia-Conyer R; Sepúlveda J; Salvatierra B; Muńoz O; Bustamante-Calvillo E; Alvarez y Muńoz T; Gutiérrez G
Salud Publica Mex; 1992; 34(2):211-21. PubMed ID: 1631734
[TBL] [Abstract][Full Text] [Related]
12. The 2001 serological survey in the Czech Republic--rubella.
Mrázová M; Smelhausová M; Sestáková Z; Svandová E; Benes C
Cent Eur J Public Health; 2003 Dec; 11 Suppl():S42-9. PubMed ID: 15080259
[TBL] [Abstract][Full Text] [Related]
13. Postinfection and postvaccination antirubella immunity.
Kańtoch M; Imbs D
Acta Virol; 1986 Sep; 30(5):381-9. PubMed ID: 2878585
[TBL] [Abstract][Full Text] [Related]
14. Current lessons from 20th century serosurveillance data on rubella.
Cooper LZ
Clin Infect Dis; 2001 Oct; 33(8):1287. PubMed ID: 11565066
[No Abstract] [Full Text] [Related]
15. Rubella Seroprevalence among the General Population in Dongguan, China.
Lin W; Wang D; Xiong Y; Tang H; Liao Z; Ni J
Jpn J Infect Dis; 2015; 68(3):192-5. PubMed ID: 25672349
[TBL] [Abstract][Full Text] [Related]
16. Rubella immune status of pregnant and non-pregnant women in Istanbul, Turkey.
Seker S; Abasiyanik MF; Salih BA
Saudi Med J; 2004 May; 25(5):575-9. PubMed ID: 15138523
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of rubella-specific IgG antibody in non-immunized pregnant women in Maiduguri, north eastern Nigeria.
Bukbuk DN; el Nafaty AU; Obed JY
Cent Eur J Public Health; 2002 Jun; 10(1-2):21-3. PubMed ID: 12096678
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
[TBL] [Abstract][Full Text] [Related]
19. [The seroepidemiology of rubella in Mexican women. A national probability survey].
Gutíerrez Trujillo G; Muñoz O; Tapia Conyer R; Bustamante Calvillo ME; Alvarez y Muñoz MT; Guiscafré Gallardo JP; Magos C; Sepúlveda J
Salud Publica Mex; 1990; 32(6):623-31. PubMed ID: 2089638
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of measles antibody in the US population, 1999-2004.
McQuillan GM; Kruszon-Moran D; Hyde TB; Forghani B; Bellini W; Dayan GH
J Infect Dis; 2007 Nov; 196(10):1459-64. PubMed ID: 18008224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
